[1. Melamed S, Ben-Sira, Ben-Shaul. Corneal endothealial changes under induced intraocular pressure elevation: a scanning and transmission electron microscopic study in rabbits. British Journal of Ophthalmology. 1980;64:164-169.10.1136/bjo.64.3.16410393807387948]Search in Google Scholar
[2. Li X, Zhang Z, Ye L, Meng J, Zhao Z, Liu Z, Hu Z. Acute ocular hypertension disrupts barrier integrity and pump function in rat corneal endothelial cells. Scientific Reports, Nature; 2017.10.1038/s41598-017-07534-9553740528761172]Search in Google Scholar
[3. Olmos LC, Lee RK. Medical and Surgical Treatment of Neovascular Glaucoma. Bascom Palmer Eye Institute, University of Miami Miller School of Medicine Miami, FL, Int Ophthalmol Clin. 2011;51(3):27–36.]Search in Google Scholar
[4. Borgman CJ. Neovascular Glaucoma: A Serious Secondary Condition. Review of Optometry; 2014.]Search in Google Scholar
[5. Satoko Nakano, Takako Nakamuro, Katsuhiko Yokoyama, Kunihiro Kiyosaki, Toshiaki Kubota, Prognostic Factor Analysis of Intraocular Pressure with Neovascular Glaucoma. Journal of Of Ophtalmology. 2016 Volume 2016 |Article ID 1205895 https://doi.org/10.1155/2016/120589510.1155/2016/1205895499251827579175]Search in Google Scholar
[6. Rodrigues AI, Sheng L. Reversing the rubeotic rampage – Current approaches in the management of neovascular glaucoma, European Ophthalmic Review. 2016;10(1):19–21.10.17925/EOR.2016.10.01.19]Search in Google Scholar
[7. Nakano S, Nakamuro T, Yokoyama K, Kiyosaki K, Kubota T. Prognostic Factor Analysis of Intraocular Pressure with Neovascular Glaucoma. J Ophtalmol; 2016.10.1155/2016/1205895]Search in Google Scholar
[8. Park J, Lee M. Short-term effects and safety of an acute increase of intraocular pressure after intravitreal bevacizumab injection on corneal endothelial cells, BMC Ophthalmology. 2018;18:17.10.1186/s12886-018-0682-9]Search in Google Scholar
[9. Sun Y, Liang Y, Zhou P, Wu H, Hou X, Ren Z, Li X, Zhao M. Anti- VEGF treatment is the key strategy for neovascular glaucoma management in the short term. BMC Ophthalmology. 2016;16:150.https://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Mark+Cedric+Gillies%2210.1186/s12886-016-0327-9500632127576739]Search in Google Scholar
[10. Gillies MC, Morlet N, Sarossy MG. Treating ophthalmic fibrosis using interferon-.alpha”, Sydney, Australia, Jan.; 1999.]Search in Google Scholar
[11. Gillies M, Su T, Sarossy M, Hollows F. Interferon-alpha 2b inhibits proliferation of human Tenon’s capsule fibroblasts”, Department of Ophthalmology P rince of Wales Hospital Ranwick, Auastralia; 199310.1007/BF009202258444359]Search in Google Scholar
[12. Gillies MC, Goldberg I, Stephanie H, Su, Tao. Glaucoma filtering surgery with interferon alpha-2b, Journal of Glaucoma. 1993;2(24).10.1097/00061198-199300240-00001]Search in Google Scholar